Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

NeuroDerm nets $41.5mm in Nasdaq IPO

Executive Summary

Ten-year-old Israeli biotech NeuroDerm Ltd. (reformulates existing neurological disease therapeutics) netted $41.5mm in its Nasdaq initial public offering of 4.5mm ordinary shares at $10, below its anticipated $13-16 range.
Deal Industry
  • Biotechnology
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register